Profiling circulating tumor cells (CTCs) from the blood is an attractive alternative to invasive and painful biopsies for cancer diagnosis. However, their low abundance, contamination with blood cells, and cell death during purification create barriers for the technique’s successful adoption in clinics. To circumvent these problems, researchers turn to single-cell technology to enrich CTCs from the blood and determine tumor characteristics.
Download this application note from BioRad to learn
The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com
© 1986-2022 The Scientist
The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.